DaVita Inc. (DVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 102.36 |
| Open | 102.35 |
| Bid | 98.91 x 800 |
| Ask | 101.17 x 900 |
| Day's Range | 98.50 - 102.60 |
| 52 Week Range | 65.28 - 116.97 |
| Volume | |
| Avg. Volume | 697,454 |
| Market Cap | 9.012B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | 20.02 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Nuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
- CNW Group
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions.
© 2023 Yahoo. All rights reserved.
